{
    "2019-03-13": [
        [
            {
                "time": "2019-03-13",
                "original_text": "Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study",
                "features": {
                    "keywords": [
                        "Theravance",
                        "TBPH",
                        "Dosing",
                        "Ulcerative Colitis",
                        "Study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "9 Great Dividend Growth Stocks to Buy",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Growth",
                        "Stocks",
                        "Buy"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "Health Care Sector Update for 03/13/2019: NVCN, CASI, LXRX, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector",
                        "Update",
                        "NVCN",
                        "CASI",
                        "LXRX",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-14",
                "original_text": "Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2019",
                "features": {
                    "keywords": [
                        "Merck",
                        "MRK",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie",
                "features": {
                    "keywords": [
                        "Biotech",
                        "AEterna Zentaris",
                        "Verastem",
                        "Copiktra",
                        "Sales",
                        "FDA",
                        "Aerie"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}